Search Results - neurodegeneration+alzheimer%27s+disease+predictive+testing

3 Results

Sort By:

Positive Unlabeled Learning With Bias Mitigation for Fair Prediction of Undiagnosed Alzheimer’s Disease (Case No. 2025-113)

Summary: UCLA researchers in the Department of Neurology have developed a software to predict the diagnosis of Alzheimer’s Disease without racial or ethnic biases. Background: Alzheimer’s Disease (AD) represents a major health and economic challenge in the United States. Despite its prevalence, Alzheimer’s remains significantly...

Published: 2/14/2025 | Inventor(s): Timothy Chang

Keywords(s): Alzheimers disease, artificial intelligence/machine learning models, electronic health records (EHR), medical bias reduction, Neurodegeneration Alzheimer's Disease Predictive Testing, neurological disorders, Neurology, personalized medicine

Category(s): Software & Algorithms > Artificial Intelligence & Machine Learning, Software & Algorithms > Data Analytics, Software & Algorithms > Digital Health, Software & Algorithms > Image Processing, Software & Algorithms > Programs, Diagnostic Markers > Aging, Therapeutics > CNS and Neurology

2021-278 Enhancement of Human Memory and Treatment of Alzheimer’s Disease by Closed -Loop Phase-Locked Brain Electric Stimulation During Sleep

SUMMARY: UCLA researchers in the department of Neurosurgery have developed an implantable brain electrode system which can modulate the brain’s activity to improve sleep and consolidation of memory, several important activities in the treatment of Alzheimer’s Disease. BACKGROUND: Sleep is universally understood to be beneficial to...

Published: 2/14/2025 | Inventor(s): Itzhak Fried, Yuval Nir, Maya Geva-Sagiv

Keywords(s): Deep Brain Stimulation, Deep Brain Stimulation Current Mirror Output Impedance, Electrical Brain Stimulation, Memory, Neurocognitive, Neurodegeneration, Neurodegeneration Alzheimer's Disease Predictive Testing, Neuromodulation, Neurostimulation

Category(s): Medical Devices > Neural Stimulation, Medical Devices > Monitoring And Recording Systems

2019-772: A Single Chain Antibody That Binds Tau Oligomers and Inhibits Seeding by Pathological Extracts From Alzheimer’s Disease

SUMMARYUCLA researchers in the Department of Chemistry & Biochemistry have developed a method for efficiently producing tau oligomers and a single-chain antibody against oligomeric tau protein with potential for theranostic utility in the treatment of Alzheimer’s and other tauopathies.BACKGROUND:Alzheimer’s disease (AD) is the most prevalent...

Published: 2/14/2025 | Inventor(s): David Eisenberg

Keywords(s): Amyloid, Antibodies, Central Nervous System, Genetic Disease, Life Science Research Tools, Neurodegeneration Alzheimer's Disease Predictive Testing, Tau Protein

Category(s): Life Science Research Tools > Antibodies, Therapeutics > CNS and Neurology